Myeloproliferative Neoplasms (MPNs) Patient Stories & Specialist Interviews
Myeloproliferative neoplasms, also referred to commonly as “MPNs,” comprise a group of diseases caused by the bone marrow overproducing red blood cells, white blood cells, or platelets.
Three of the most common types of MPNs are essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).
Explore below to read and watch in-depth MPN patient stories and get access to top MPN specialists, who detail the latest on emerging MPN treatments and clinical trials.
MPN Patient Stories
1st Symptoms: Nosebleeds (unrelated) led to blood work, revealing high WBCs
Treatment: Clinical trial, Gazyva (obinutuxumab) and steroids, Jakafi (ruxolitinib), Inrebic (fedratinib), Reblozyl (luspatercept)
MPN Specialist Conversations
Srdan Verstovsek, MD, PhD
Role: Director, Clinical Research Center for MPNs at MD Anderson; Section Chief, MPNs; Prof., Dept. of Leukemia
Focus: Myeloproliferative neoplasms (MPN)
Institution: MD Anderson
Myeloproliferative Neoplasm FAQs
Myelofibrosis is a rare cancer of the bone marrow. Learn more about myleofibrosis symptoms, diagnosis, treatment and more.
Polycythemia vera (PV) is a rare, chronic blood disorder. Learn more about polycythemia vera symptoms, diagnosis, treatment and more.
Essential thrombocythemia (ET) is a rare form of blood cancer in which the bone marrow overproduces platelets. Learn more about essential thrombocythemia symptoms, diagnosis, treatment and more.